Clinical Trial Update: A Study Evaluating the Absorption Of Varenicline Through The Skin Following Once Daily Application Of A Patch For 14 Days [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the skin absorption of varenicline from a once-daily patch worn for 14 days in the context of smoking cessation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Varenicline (Chantix) (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Phase 1 | Status: COMPLETED